JAN 31, 2017 10:00 AM PST

WEBINAR: The Vital Role of Transformative Diagnostics in Optimizing Antimicrobial Stewardship

Sponsored by: T2 Biosystems, Inc.
Speaker
  • Chief Medical Officer, T2 Biosystems and Professor Emeritus Departments of Pathology and Epidemiology University of Iowa College of Medicine and College of Public Health
    Biography
      Dr. Pfaller is an accomplished physician, educator, and researcher in the areas of antifungal agents and resistance, epidemiology of bacterial and fungal infections, and the role of the clinical microbiology laboratory in hospital infection control. He is a co-editor in chief of the 11th edition of ASM Manual of Clinical Microbiology and co-author of Medical Microbiology, 7th Edition and has authored over 700 articles in peer-reviewed journals. Dr. Pfaller currently serves as Chief Medical Officer at T2 Biosystems.

    Abstract

    DATE: January 31, 2017
    TIME: 10:00am PT/1:00pm ET

    Learn from renowned clinical expert, Dr. Michael A. Pfaller, as he discusses the critical role of diagnostics and antimicrobial stewardship in improving patient outcomes and reducing overall healthcare costs.  

    Dr. Pfaller will discuss how a robust antimicrobial stewardship program, when coupled with transformative diagnostic tools such as T2MR® and the T2Candida® Panel, offers clinicians the opportunity for early, targeted antimicrobial interventions with the potential to improve patient outcomes and reduce healthcare costs. 

    Dr. Pfaller will also review current best practices for diagnosing and managing patients at risk for sepsis and provide an overview of forthcoming rapid, highly sensitive, direct-from-blood diagnostics.

    Learning Objectives:

    • Understand the critical role of diagnostics and antimicrobial stewardship in improving patient outcomes for patients at high risk for sepsis and invasive candidiasis
    • Understand the potential of rapid diagnostics, such as the T2Candida® Panel and T2Dx® Instrument, to improve patient outcomes and reduce healthcare costs through the timely detection of deadly sepsis pathogens

    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 09, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 09, 2020 9:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 09, 2020 TIME: 09:00am PDT Hematopoietic stem cells (HSCs) ensure homeostasis of blood throughout life. In this webinar, we share insights into the smart and easy isolation, c...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    Loading Comments...
    Show Resources
    Attendees
    • See more